Svrcek M - Search Results

1

Expression of a mutant HSP110 sensitizes colorectal cancer cells to chemotherapy and improves disease prognosis.

Dorard C, de Thonel A, Collura A, Marisa L, Svrcek M, Lagrange A, Jego G, Wanherdrick K, Joly AL, Buhard O, Gobbo J, Penard-Lacronique V, Zouali H, Tubacher E, Kirzin S, Selves J, Milano G, Etienne-Grimaldi MC, Bengrine-Lefèvre L, Louvet C, Tournigand C, Lefèvre JH, Parc Y, Tiret E, Fléjou JF, Gaub MP, Garrido C, Duval A. Dorard C, et al. Among authors: svrcek m. Nat Med. 2011 Sep 25;17(10):1283-9. doi: 10.1038/nm.2457. Nat Med. 2011. PMID: 21946539

2

COX-2, inflammatory secreted PLA2, and cytoplasmic PLA2 protein expression in small bowel adenocarcinomas compared with colorectal adenocarcinomas.

Wendum D, Svrcek M, Rigau V, Boëlle PY, Sebbagh N, Parc R, Masliah J, Trugnan G, Fléjou JF. Wendum D, et al. Among authors: svrcek m. Mod Pathol. 2003 Feb;16(2):130-6. doi: 10.1097/01.MP.0000052101.58988.1F. Mod Pathol. 2003. PMID: 12591965

3

Ciliated hepatic foregut cyst with extensive squamous metaplasia: report of a case.

Ben Mena N, Zalinski S, Svrcek M, Lewin M, Fléjou JF, Wendum D, Paye F. Ben Mena N, et al. Among authors: svrcek m. Virchows Arch. 2006 Dec;449(6):730-3. doi: 10.1007/s00428-006-0320-4. Epub 2006 Nov 8. Virchows Arch. 2006. PMID: 17106708

4

Expression of epidermal growth factor receptor (EGFR) is frequent in inflammatory bowel disease (IBD)-associated intestinal cancer.

Svrcek M, Cosnes J, Tiret E, Bennis M, Parc Y, Fléjou JF. Svrcek M, et al. Virchows Arch. 2007 Feb;450(2):243-4. doi: 10.1007/s00428-006-0338-7. Virchows Arch. 2007. PMID: 17123105 No abstract available.

5

[Intrabiliary metastasis in colorectal cancer].

Lefevre JH, Svrcek M, Frileux P, Paye F. Lefevre JH, et al. Among authors: svrcek m. Gastroenterol Clin Biol. 2007 Feb;31(2):146-8. doi: 10.1016/s0399-8320(07)89345-6. Gastroenterol Clin Biol. 2007. PMID: 17347621 Free article. French.

6

Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis.

Svrcek M, Cosnes J, Beaugerie L, Parc R, Bennis M, Tiret E, Fléjou JF. Svrcek M, et al. Histopathology. 2007 Apr;50(5):574-83. doi: 10.1111/j.1365-2559.2007.02663.x. Histopathology. 2007. PMID: 17394493

7

Regressive liver adenomatosis following androgenic progestin therapy withdrawal: a case report with a 10-year follow-up and a molecular analysis.

Svrcek M, Jeannot E, Arrivé L, Poupon R, Fromont G, Fléjou JF, Zucman-Rossi J, Bouchard P, Wendum D. Svrcek M, et al. Eur J Endocrinol. 2007 Jun;156(6):617-21. doi: 10.1530/EJE-07-0020. Eur J Endocrinol. 2007. PMID: 17535860

8

[Acinar cell carcinoma of the pancreas with predominant intraductal growth: report of a case].

Svrcek M, Lesurtel M, Lewin M, Afchain P, Fabre M, Scoazec JY, Parc R, Fléjou JF. Svrcek M, et al. Gastroenterol Clin Biol. 2007 May;31(5):543-6. doi: 10.1016/s0399-8320(07)89425-5. Gastroenterol Clin Biol. 2007. PMID: 17541347 Free article. French.

9

[A rare and misleading gastric lesion].

Svrcek M, de Mauroy C, Fléjou JF. Svrcek M, et al. Ann Pathol. 2007 Feb;27(1):49-51. doi: 10.1016/s0242-6498(07)88687-1. Ann Pathol. 2007. PMID: 17568362 French. No abstract available.

10

Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instability.

Svrcek M, El-Bchiri J, Chalastanis A, Capel E, Dumont S, Buhard O, Oliveira C, Seruca R, Bossard C, Mosnier JF, Berger F, Leteurtre E, Lavergne-Slove A, Chenard MP, Hamelin R, Cosnes J, Beaugerie L, Tiret E, Duval A, Fléjou JF. Svrcek M, et al. J Clin Oncol. 2007 Sep 20;25(27):4231-8. doi: 10.1200/JCO.2007.10.9744. J Clin Oncol. 2007. PMID: 17878476

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters